Introduction
An iron chelate, ferric nitrilotriacetate (Fe-NTA), induces renal proximal tubular damage, a consequence of a Fenton-like reaction in vivo, that ultimately leads to a high incidence of renal cell carcinoma (RCC) in rodents (Ebina et al., 1986; Li et al., 1987; Toyokuni et al., 1990) . Fe-NTA-induced renal carcinogenesis in rats is a unique model characterized by (1) high incidence of pulmonary metastasis and peritoneal invasion, (2) the presence of molecules covalently modified by reactive oxygen species (ROS) (Toyokuni, 1999) in the target organ during carcinogenesis and (3) inhibition of not only acute renal damage (Hamazaki et al., 1988) but also tumor incidence (Zhang et al., 1997) by pretreatment with a lipid-soluble antioxidant, a-tocopherol. We previously reported an increase in a variety of oxidatively modified compounds such as 8-oxoguanine (Toyokuni et al., 1994a (Toyokuni et al., , 1997b , thyminetyrosine crosslinks (Toyokuni et al., 1995a) , thiobarbituric acid-reactive substances (Toyokuni et al., 1994b) , saturated and unsaturated mutagenic aldehydes, including 4-hydroxy-2-nonenal (HNE) and malondialdehyde (MDA) (Toyokuni et al., 1997a) , and HNE-or MDAmodified proteins (Toyokuni et al., 1994b; Tanaka et al., 1997) in the kidney after Fe-NTA administration.
Since oxidative stress may be intimately associated with carcinogenesis (Ames et al., 1991) , it would be of great interest to find the responsible gene(s) in this carcinogenesis model. Recently, we found frequent allelic losses on rat chromosomes 5 and 8 by genetic analysis of Fe-NTA-induced RCCs, which led to the conclusion that p15 INK4B and p16 INK4A (p16) tumor suppressor genes are frequently inactivated either by deletion, point mutation or methylation of the promoter region in such RCCs (Tanaka et al., 1999; Hiroyasu et al., 2002) . However, since no occurrence of RCC has been observed in p16 knockout mice studies (Serrano et al., 1996; Krimpenfort et al., 2001; Sharpless et al., 2001) , other alterations might also play a role in oxidative stress-induced carcinogenesis. In a more recent attempt to find the gene(s) responsible for Fe-NTAinduced RCCs, we modified a fluorescent differential display (FDD) technique, and by screening approximately 84 000 transcripts isolated 20 differentially expressed clones, including annexin 2 (Anx2; p36, lipocortin II, chromobindin VIII or placental anticoagulant protein IV) (Tanaka et al., 2000) .
We report here for the first time that expression of Anx2 in the renal tubular cells is regulated by oxidative stress and that persistent overexpression of Anx2 plays a role in proliferation and metastasis of such oxidative stress-induced cancer cells.
Results

Isolation of genes differentially expressed in Fe-NTA-induced RCCs
The FDD technique identified 20 independent cDNA clones, including clone 208 (Figure 1a , arrowhead), which was confirmed to be differentially expressed in the Fe-NTA-induced RCCs by Northern blot analysis. Clone 208 hybridized to a transcript of approximately 1.4 kb (Figure 1b) . After subcloning and sequencing, BLAST search revealed that clone 208 was located at the 3 0 region of rat Anx2 cDNA. Independently obtained clones 246 and 421 were also identified as rat Anx2 cDNAs.
Increased expression of Anx2 in Fe-NTA-induced RCCs
Anx2 message was significantly increased in 10 primary Fe-NTA-induced RCCs, as shown in Figure 2a (right half), whereas only a low level of expression was observed in the untreated control kidney by Northern blot. We confirmed this by immunoprecipitation and Western blot analysis (Figure 2b ). Furthermore, the increased level of Anx2 was associated with phosphorylation of the serine and tyrosine residues, and coimmunoprecipitated with actin, which was also phosphorylated at serine and tyrosine residues (Figure 2c ). The degree of phosphorylation was greater at the tyrosine residue in Anx2 whereas it was greater at the serine residue in actin.
Induction of Anx2 by oxidative stress in vivo
We next examined whether Anx2 is induced by oxidative stress in rat kidney. Northern and Western blot analyses were used to determine whether Anx2 is induced during the acute and chronic phases of Fe-NTA treatment. Diffuse proximal tubular necrosis is observed from 3 h after a single intraperitoneal administration of 15 mg iron/kg Fe-NTA (sublethal toxic dose), until 24 h, whereas regeneration dominates after 48 h (Hamazaki et al., 1985; Toyokuni et al., 1994a) . Figure 2a (left half) shows changes in Anx2 message levels after Fe-NTA Figure 1 Identification of a clone by fluorescent differential display and Northern blot analysis. (a) Selection of a clone by fluorescent differential display. Total RNA (lane 1, untreated control kidney; lane 2, kidney after 6-week treatment with Fe-NTA; lanes 3 and 5, Fe-NTA-induced RCCs; lane 4, a cell line established from an Fe-NTA-induced RCC) was reverse-transcribed and used as the substrate for PCR amplification in the presence of a rhodamine-labeled anchor primer and an arbitrary primer. Amplified DNA fragments were analysed by polyacrylamide gel electrophoresis as described in Materials and methods. The selected fragment (clone 208; 480 bp) shown by an arrowhead was identified as annexin 2. Markers are a 100 bp ladder. (b) Northern blot analysis. Total RNA (20 mg per each lane; lane 1, untreated control kidney; lanes 2/3 and lanes 4/5, paired samples from Fe-NTA-induced RCCs and the nontumorous portion of the respective kidney) was subjected to Northern blot using the cloned DNA fragment (shown in Figure 1a ) as a probe. RCCs, not nontumorous portions, revealed high expression. Glyceraldehyde-3-phosphate dehydrogenase (GAPDH) served as a loading control Figure 2 Increased expression and protein levels of Anx2 in the kidney after Fe-NTA-induced oxidative stress and in Fe-NTAinduced RCCs. (a) Northern blot analysis. Poly(A)-rich RNA (2 mg) was isolated and subjected to a sensitive Northern blot analysis. Kidney samples 1-96 h after a single administration of Fe-NTA, kidney samples after repeated administration of Fe-NTA and all the RCC samples examined showed high expression of Anx2. Rehybridization with b-actin probe was used as a control. (b, c) Immunoprecipitation and Western blot analysis. Immunoprecipitation was performed with anti-Anx2 antibody, followed by Western blot analysis. Western blot analysis of lysates is also shown in (b). (b) An increase in Anx2 protein was observed in the kidney after a single or repeated Fe-NTA administration, and in RCCs. (c) The increase in Anx2 protein in RCCs and FRCC cell lines was associated with coimmunoprecipitation with phosphorylated actin as well as phosphorylation of Anx2 itself (arrowheads). IP, immunoprecipitation; W, Western blot analysis; H, heavy chain of immunoglobulin; P-Ser, phosphorylated serine residue; P-Tyr, phosphorylated tyrosine residue administration. The level of Anx2 message was significantly increased 3 h after Fe-NTA administration, reached a plateau at 24 h, then gradually decreased, and returned to the control level after 96 h. On the other hand, after repeated Fe-NTA treatment for 1-3 weeks, renal proximal tubular cells adjust themselves to Fe-NTA-induced oxidative stress, and show almost no necrosis, but accumulate aldehyde-modified proteins in the cytoplasm (Toyokuni et al., 1997a) . At this stage, there was an increase in the levels of Anx2 message and protein (Figure 2a and b) .
Immunohistochemical analysis
The localization of Anx2 was studied using an immunohistochemical approach. In the kidneys of untreated control rats, weak immunostaining was observed in the glomeruli and vessels, especially on the endothelia (Figure 3a) . Plasma membrane immunostaining was observed 6 h after Fe-NTA administration on the surviving proximal tubular cells and the cells of the outer stripe of the outer medulla. The staining was intensified at 24 h (Figure 3b and c) . At 48 h, regenerating proximal tubular cells showed strong cytoplasmic immunostaining ( Figure 3d ). After repeated administration of Fe-NTA for 3 weeks, intense staining was observed in the cytoplasm and nuclei of giant regenerative cells with atypical nuclei of possible proximal tubular origin (karyomegalic cells) (Figure 3e and f) (Toyokuni et al., 1994a) . RCCs revealed strong immunostaining mainly on the plasma membrane ( Figure  3g and h). There was a difference in the staining intensity among tumors, which was consistent with the results of Western blot analysis (data not shown).
Anx2 and metastasis
Although a high level of Anx2 message was constantly observed in the RCCs, its Anx2 protein level as determined by immunoprecipitation and Western blot analysis was more varied. The Anx2 protein level of the RCCs with pulmonary metastasis was significantly higher than that of RCCs with no metastasis (Figure 4 ; 0.50770.130 vs 0.04770.027, arbitrary unit for densitometric analysis; Po0.05, means7s.e.m., N ¼ 13 and 5, respectively).
Induction of Anx2 by oxidative stress in vitro
An in vitro assay was used to test whether the induction of Anx2 is indeed caused by oxidative stress. LLC-PK1 was selected since it is a nontransformed cell line derived from normal renal tubular cells (Hull et al., 1976) . Hydrogen peroxide permeates the cell membrane by passive diffusion, and is thought to eventually be converted to ROS such as hydroxyl radicals in the presence of transition metals (Halliwell and Gutteridge, Figure 3 Immunohistochemical analysis of Anx2 in the kidney after oxidative stress by Fe-NTA administration, and in Fe-NTAinduced RCCs (bar, 100 mm in (a-h); 25 mm only in the inset of (h); (a-d, f) with no nuclear counterstaining; (e, g, h) hematoxylin nuclear staining; (h, inset) propidium iodide nuclear counterstaining). Immunoprecipitation was performed with anti-Anx2 antibody, followed by Western blot analysis. RCCs with pulmonary metastasis showed much higher levels of Anx2 than those without metastasis. H, heavy chain of immunoglobulin 1999), or to oxidize the sulfhydryls of cysteine residues to disulfide bonds to modify the function of proteins (Sun and Oberley, 1996) . In the time-course and dosedependency experiments, we found that treatment of the cells with 10-100 mM H 2 O 2 for 30 min significantly increased the protein levels of Anx2, with a peak at 3-6 h. The same tendency was observed in a rat hepatocyte cell line, RL34 (Figure 5a ). Furthermore, this induction was inhibited by pretreatment for 1 h with 20 mM NAC, 100 mM PDTC or 3000 U/ml catalase ( Figure 5b ). These results suggest that the expression of Anx2 is regulated by the cellular redox status.
Messenger RNA stability
The degradation rate of Anx2 mRNA was studied in LLC-PK1 cells after stopping the transcription with actinomycin D. The half-life of Anx2 mRNA in the control cells was longer than that of 10 mM H 2 O 2 -treated cells in the present experimental condition ( Figure 6 ).
Effects of Anx2 overexpression on cell proliferation
At 6 h after transfection of Anx2 expression vector, LLC-PK1 cells or COS7 cells were subjected to a cell proliferation assay based on the incorporation of bromodeoxyuridine (BrdU). The transfection efficiency was 30-50% by in situ hybridization. The incorporation of BrdU was increased by 34% as compared with the transfection of empty vector in LLC-PK1 cells. However, no significant increase in the incorporation of BrdU was observed in COS7 cells, in which high expression of Anx2 is observed even without transfection. Therefore, we undertook to evaluate the effect of Anx2 depletion.
Effects of antisense phosphorothioate oligonucleotides on cell proliferation
Antisense phosphorothioate oligonucleotides inhibit gene expression by binding to the complementary sites on mRNAs, resulting in RNase H-mediated mRNA degradation. We measured the protein level of Anx2 in cell lines derived from Fe-NTA-induced primary RCCs (FRCC series; refer to Materials and methods section) after transfection with either sense or antisense oligonucleotides. As shown in Figure 5c , only cells transfected with antisense oligonucleotides showed a decrease in the levels of Anx2, which started as early as 3 h after treatment. No Anx2 protein was at the detectable level at 36 h. On the other hand, no change in Anx2 protein level was observed in the cells transfected with sense phosphorothioate oligonucleotides (S), or treated only with polyamine transfection reagent (LT2). These results confirm the specificity of the antisense oligonucleotides used in the present experiments. The protein levels of Anx6 and Anx11 were unchanged 4 h after transfection of Anx2 antisense oligonucleotides (data not shown).
Next we examined the effects of antisense oligonucleotides on the proliferation of FRCC cell lines. Three independent cell lines (FRCC-001, FRCC-562 and FRCC-483) transfected with antisense oligonucleotides gradually lost the ability to incorporate BrdU, which was consistent with the decrease in the level of Anx2 protein (Figure 7 ; LT2 þ AS). In contrast, there was no significant change in the rate of BrdU incorporation 
Induction of apoptosis by Anx2 antisense transfection into FRCC cells
We then studied the morphological changes induced by the Anx2 antisense transfection. The FRCC cells treated with antisense phosphorothioate oligonucleotides gradually lost adherence ability beginning 6 h after treatment, and the majority of the cells were floating in the medium at 36 h. These floating cells were stained with trypan blue. There was no significant difference in cell morphology between cells treated with either sense oligonucleotides or only transfection reagent and the untreated control cells (data not shown).
To determine whether the reduced proliferation and adherence ability was due to apoptosis, FRCC cells treated with antisense oligonucleotides were evaluated by the terminal deoxynucleotidyl transferase end labeling (TUNEL) method. There was no detectable apoptosis at 3 h. However, after 24 h of treatment, significant induction of apoptosis was observed in the FRCC cells treated with Anx2 antisense oligonucleotides, but not with sense oligonucleotides (Figure 8a and  b) . Further, we quantitatively analysed DNA fragmentation in antisense-treated FRCC cells. When two independent cell lines were transfected with antisense oligonucleotides (LT2 þ AS), a strong increase in the rate of apoptosis was observed, as determined by a cellular DNA fragmentation assay (Figure 8c ). Induction of apoptosis was not observed after sense treatment (LT2 þ S) or treatment only with transfection reagent (LT2) (Figure 8a and c) .
Discussion
By differential display analysis, Anx2 was identified as one of the candidate responsible genes in Fe-NTA-induced RCCs. Thus far, two decades of studies have revealed multiple diverse functions of Anx2. Anx2 was first reported as a 36 kDa phosphorylated polypeptide that appears in Rous sarcoma virus-transformed chick embryo cells (Radke and Martin, 1979) . It was shown to be a substrate of protein tyrosine kinases such as pp60 src (Radke et al., 1980) and of epidermal growth factor receptor (Erikson et al., 1981) . Anx2 is also a substrate of protein kinase C (Gould et al., 1986) , and has been reported to be a calcium-regulated, phospholipid-binding protein on endothelial cells, macrophages and some tumor cells.
The second major function of Anx2 is acting as a phopholipase A 2 inhibitor in combination with p11 (Haigler et al., 1987; Wu et al., 1997) involved in the inhibition of platelet aggregation, which is in accord with the recent finding that Anx2 itself is a cell-surface receptor for plasminogen and its activator t-PA (tissuetype plasminogen activator) (Hajjar and Menell, 1997) . Furthermore, abnormally high levels of Anx2 on acute promyelocytic leukemia cells were found to increase the production of plasmin, a fibrinolytic protein, suggesting that overexpression of Anx2 may be responsible for the hemorrhagic complications of acute promyelocytic leukemia (Menell et al., 1999) .
Another role of Anx2 includes acting as one of the primer recognition proteins that are cofactors for DNA polymerase a (Jindal et al., 1991) . Thus, Anx2 is associated with the regulation of DNA synthesis, and probably also with the cell cycle (Chiang et al., 1993) and cellular proliferation (Kumble et al., 1992b) . Other functions include regulation of membrane trafficking such as exocytosis (Liu et al., 1996; Konig et al., 1998) and actin filament bundling (Jones et al., 1992) , immunosuppression in RCC (Aarli et al., 1997) and insulin-induced signal transduction (Biener et al., 1996) . However, few studies have focused on the role of Anx2 in the pathological conditions induced by ROS.
In the present study, we have for the first time shown that oxidative renal tubular damage rapidly enhances the expression of Anx2 (Figure 2a) . Interestingly, there was no detectable amount of Anx2 protein in the control renal proximal tubules in both immunoprecipitation and immunohistochemical analyses. In contrast, cultured cells, including HeLa cells (data not shown), without any treatment always showed moderate to high levels of Anx2 protein (Figure 5a-c) . After repeated administration of Fe-NTA, a low level of Anx2 protein was detected in the kidney, and RCCs always contained detectable amounts of Anx2 protein, although the amount varied depending on the tumors. Anx2 was phosphorylated at serine and tyrosine residues albeit not in high level, suggesting that the responsible kinase systems were simultaneously operating. Furthermore, Anx2 was coimmunoprecipitated with phosphorylated actin when high levels of Anx2 were detected. This strongly suggests the involvement of Anx2 in the motility of cancer cells as well as of regenerating tubular cells.
Then, we carried out an in vitro study. Anx2 was induced by H 2 O 2 in cell culture experiments using LLC-PK1 porcine renal tubular cells or RL34 rat hepatocytes (Figure 5a ). This is a standard procedure to show the involvement of redox regulation (Devary et al., 1991; Li and Karin, 1999) . Phosphorylation of serine and tyrosine residues of Anx2 was observed in the untreated LLC-PK1 cells at a low level, and it was increased after oxidative stress (data not shown). This observation might stress the difference between cells in the organ and cultured cells in the flask. The half-life of Anx2 mRNA in LLC-PK1 cells after H 2 O 2 exposure was rather shorter than that of untreated cells (Figure 6 ), supporting the increased transcription of annexin 2 gene after oxidative stress. Since this induction was inhibited by pretreatment with antioxidants (NAC, PDTC and catalase), we concluded that expression of Anx2 is redox-sensitive, at least in some of the nontransformed cells. The same tendency was also observed in HeLa cells although the induction ratio of Anx2 protein was low (data not shown). The promoter region of rat Anx2 contains a variety of motifs for the binding of such transcription factors as c-Rel, NF-kB and AP-1, warranting further investigation. Orchestrated transcriptional regulation via these sites is probably responsible for the high expression of Anx2 during oxidative stress. Our results are consistent with a recent finding that in endothelial cells treated with homocysteine, which induces oxidative stress via direct interaction with a free thiol (C9 of Anx2) (Hajjar and Jacovina, 1998) , the rate of Anx2 synthesis is doubled, as shown by pulsechase studies (Chacko et al., 1998) . Although several studies show secretion of Anx2 either into culture media (Zhao et al., 2003) or sera (Aarli et al., 1997) , we failed to detect secreted Anx2 in the in vitro experiments (data not shown).
In this study, immunohistochemical analyses revealed intriguing findings. Anx2 was observed to be associated with the plasma membrane of surviving renal proximal tubular cells and tubular cells at the outer stripe of the outer medulla 24 h after Fe-NTA administration, but the localization was altered mainly to the cytoplasm at 48 h (Figure 3b-d) . We believe that this phenomenon is associated with the regeneration process, suggesting an alteration of the role of Anx2 from cellular protection to promotion of proliferation. In addition, intense staining was observed in the karyomegalic cells after repeated Fe-NTA treatment, and also mainly associated with the plasma membrane in the Fe-NTA-induced RCCs. Only karyomegalic cells revealed strong nuclear staining (Figure 3e and f) . This may be associated with the DNA repair and replication process through the activity of primer recognition, as previously described (Jindal et al., 1991) . At this stage of carcinogenesis, allelic loss of p16 tumor suppressor gene is already observed (Hiroyasu et al., 2002) . Intracellular localization of Anx2 appears to be closely associated with its ongoing distinct function.
There has been a major recent advance in the structural analysis of annexins. Annexins are a family of proteins, composed of two principal domains: the divergent NH 2 -terminal 'head (tail)' with phosphorylation sites and the conserved COOH-terminal protein core (Gerke and Moss, 2002) . This core comprises four segments of internal and interannexin homology. There is a reversible change in the conformation of peripheral membrane-associated and fully membrane-integrated forms (Langen et al., 1998) . Phosphorylation of Anx2 by protein kinase C inhibits aggregation of lipid vesicles, a model of catecholamine release by exocytosis (Johnstone et al., 1992) . It is possible that Anx2 is integrated to plasma membrane via phosphorylation signal of protein kinase C. Our ongoing study shows the activation of protein kinase Ca (unpublished data).
Pulmonary metastasis was associated with high levels of Anx2 protein at the primary RCCs (Figure 4) . During the process of metastasis, tumor cells migrate via the inferior vena cava and pulmonary artery, according to our microscopic observations. Anx2 protein associated with the tumor plasma membrane may have the prometastatic effects of preventing coagulation, oxidative stress and immunological surveillance.
Increased expression of Anx2 has been observed in a variety of malignant tumors such as pancreatic adenocarcinoma of Syrian hamsters (Kumble et al., 1992a) , and human hepatocellular carcinoma (Frohrich et al., 1990 ), brain tumor (Reeves et al., 1992) and gastric carcinoma (Emoto et al., 2001 ). The exception is human prostate cancer in which loss of Anx2 was observed (Chetcuti et al., 2001) . It has also been reported that the expression of Anx2 was induced in several sets of transformed cells irrespective of the nature of oncogene products including v-Ha-ras-, v-mosor SV40-tumor antigen (Ozaki and Sakiyama, 1993) . Studies would be necessary to evaluate whether oxidative stress is associated with those previous reports.
Expanding on the obtained results, we attempted the transfection of Anx2 to see whether it altered cell proliferation. Nontransformed LLC-PK1 cells showed a significant increase in proliferation (34%). Then, we studied the function of Anx2 in RCC cell lines established from Fe-NTA-induced rat RCCs . Since these cell lines show high levels of Anx2 protein (Figure 5c ), we transfected antisense phosphorothioate oligonucleotides rather than Anx2 expression vector. Indeed, transfection of Anx2 did not change the proliferation of FRCC cells (unpublished data). The transfection of antisense oligonucleotides significantly reduced the level of Anx2 protein to almost nil 36 h after treatment, at which time cell proliferation was suppressed and apoptosis was induced (Figures 7 and 8 ). This suggests that expression of Anx2 is necessary for the proliferation of FRCC cells, although we cannot completely rule out the possibility that expression of genes other than Anx6 and Anx11 was simultaneously affected by this treatment.
Although oxidative stress has been considered for a long time to be exclusively toxic to cells, there is now evidence that it is involved in a variety of regulatory events, such as signal transduction, gene transcription, cell activation and proliferation (Nose et al., 1991; Toyokuni, 1999; Forman et al., 2002) . Our present findings suggest that the expression of Anx2 is closely associated with oxidative stress in cancer cells, which is consistent with the hypothesis of 'persistent oxidative stress in cancer' (Toyokuni et al., 1995b) . Furthermore, Anx2 may play a role in the invasive potential of tumors since the plasminogen proteolytic system plays a central role in tumor cell invasion through interactions with secreted proteases (Mignatti et al., 1986) . Activation of t-PA via Anx2 is more specifically associated with neoplastic transformation and the invasive phenotype, whereas the urokinase-type PA (u-PA)/u-PA receptor system might be more relevant to inflammatory or nonneoplastic events (Paciucci et al., 1998) . These findings suggest that antagonizing Anx2 of carcinoma cells or interruption of 'persistent oxidative stress' hopefully results in inhibition of cellular proliferation and induction of apoptosis in oxidative stress-induced cancers. In this context, gene therapy targeted at Anx2 or searching for Anx2 antagonists might be a promising therapeutic approach.
In summary, our data obtained from Fe-NTAinduced renal carcinogenesis model suggest a link among oxidative stress, plasmin/kinase systems and proliferation/metastasis through Anx2. Activation of the plasminogen proteolytic system via oxidative stress may contribute to the invasive nature of transformed or carcinoma cells. Finally, Anx2 is redox-sensitive and persistent activation of this adaptive pathway may play a role in proliferation and metastasis of Fe-NTAinduced RCCs. The apoptotic pathway induced by Anx2 depletion, the regulation of the Anx2 promoter region and Anx2 modification, as well as Anx2-targeted gene therapy trials warrant further investigation.
Materials and methods
Tissue samples, cell cultures and chemicals
Fe-NTA solution was prepared as previously described (Toyokuni et al., 1994b) . Fe-NTA-induced RCCs were produced after a previously described protocol (Nishiyama et al., 1995) . The acute study of a single injection and the subacute study of repeated injections were carried out as previously described using 5-week-old male Wistar rats (Shizuoka Laboratory Animal Center) (Toyokuni et al., 1994a) . Tumorous and non-tumorous portions of renal tissues were collected and stored frozen at À801C.
The LLC-PK1 and COS7 cell lines were obtained through the American Type Culture Collection (Manassas, VA, USA). The RL34 cell line was from Health Science Research Resources Bank (Osaka, Japan). FRCC-001, FRCC-483 and FRCC-562 cell lines were established from primary Fe-NTAinduced rat RCCs according to a previously described procedure (Nakanishi et al., 1996) . The cell cultures were maintained either in Medium 199 for LLC-PK1 or in Dulbecco's modified Eagle's medium for COS7, RL34 and the FRCC series (GIBCO, Rockville, MD, USA) supplemented with 10% fetal calf serum (FCS) under 5% CO 2 in air at 371C. H 2 O 2 was from Nacalai Tesque (Kyoto, Japan). NAC, catalase and PDTC were obtained from Sigma (St Louis, MO, USA). NAC solution was used after adjusting the pH to 7.4 with NaOH. Treatment of cells with H 2 O 2 (1 Â 10 5 LLC-PK1 or RL34 cells per 30-mm dish) was carried out in a medium without FCS for 30 min. Thereafter, cells were washed with Dulbecco's phosphate-buffered saline (PBS(À)) and returned to the medium with FCS. Antioxidant treatment with either 20 mM NAC, 100 mM PDTC or 3000 U/ml catalase was carried out for 1 h prior to H 2 O 2 treatment, and residual reagents were removed by washing twice with PBS(À).
RNA isolation and FDD analysis
Total RNA was isolated by means of a modified acid guanidinium phenol chloroform method (Isogen, Nippon Gene, Tokyo). Poly(A)-rich RNA was isolated using oligo(dT)-latex beads (Nippon Roche, Tokyo). For FDD analyses, total RNA was isolated from untreated control rat kidney (1-year-old), a nontumorous portion of the kidney (1-year-old) treated according to the carcinogenesis protocol, two RCC tissues (low-and high-grade; RCC-1 and RCC-2, respectively) and an RCC cell line established from the corresponding high-grade tumor (FRCC001). Total RNA was treated with RNase-free DNase using a message clean kit (GenHunter Corp., Brooklyn, MA, USA) and an aliquot (500 mg) of total RNA was reverse-transcribed with a first-strand cDNA synthesis kit (Amersham Pharmacia Biotech). Arbitrary primers (oligonucleotides of 20-22 bp) were used. The anchor primer was 5 0 -CCCGGATCCd(T) 15 V-3 0 labeled with rhodamine at its 5 0 end. FDD was carried out as previously described (Tanaka et al., 2000) . A measure of 5 ml aliquots of each polymerase chain reaction (PCR) product were analysed by electrophoresis on 4% polyacrylamide gels in 7 M urea at 40 W constant power for 2-3 h. DNA in the gels was visualized using FMBIO-100 (Takara Bio, Shiga). Fragments of interest were cut out from the gel, reamplified by PCR using the corresponding primer pair, and cloned into the pBluescript II SK( þ ) vector (Stratagene, La Jolla, CA, USA) following TA cloning (Invitrogen, Tokyo).
Northern blot analysis
For Northern blot analysis, poly(A)-rich RNA samples (2 mg) were separated by electrophoresis on a 1% agarose gel containing formaldehyde and transferred onto a nylon membrane. DNA fragments of Anx2 (GenBank NM 019905; 1-1169) were amplified by PCR (sense, 5
0 -AGGCTCTCTG CAATAGGTGC-3 0 ; antisense, 5 0 -TTCACAGGGAGGAG TTCAGG-3 0 ) using rat kidney cDNA as a substrate, and subjected to TA cloning. Thereafter, the vector plasmids were amplified, digested with XbaI (1-1120; Takara Bio, Shiga), purified and used as a probe after labeling with [a- 32 P]dCTP by the random priming method (Megaprime DNA labelling kit, Amersham Pharmacia Biotech, Tokyo). Hybridization was carried out as previously described (Tanaka et al., 1997) . ULTRAHyb ultrasensitive hybridization buffer (Ambion, Austin, TX, USA) was used for sensitive detection. Autoradiography was performed with an imaging plate and BAS2000 (Fuji Film, Tokyo).
Messenger RNA stability assay Preconfluent LLC-PK1 cells grown in 100-mm dishes were exposed to 0 or 10 mM H 2 O 2 as previously described, and then to media containing 2.5 mg/ml actinomycin D (Sigma) (Ramasamy et al., 1998; Zhou et al., 2003) . The culture media were removed at 0, 1, 3 and 6 h post actinomycin D treatment. The cell monolayers were subjected to total RNA isolation and reverse transcription (RT)-PCR with a One Step RNA PCR kit according to the manufacturer's protocol (TakaraBio). The primers for porcine Anx2 and b-actin were as follows: Anx2, sense 5 0 -GACATTGCCTTTGCCTACCA-3 0 and antisense 5 0 -GAGTCCTCGTCAGTCCCCAG-3 0 (173 bp, annealing temperature 561C, 28 cycles) based on GenBank AU058987; b-actin, sense 5 0 -TCAAGGAGAAGCTCTGCTACGTC-3 0 and antisense 5 0 -CATGATCGAGTTGAAGGTGGTCT-3 0 (215 bp, annealing temperature 561C, 23 cycles) based on GenBank AJ312193. PCR was initially performed with different cycle numbers to find the optimal number for quantitative amplification of the target products. These primer pairs were designed to amplify cDNA encompassing more than two exons to exclude the amplification of genomic DNA. NIH image freeware (ver. 1.62,http://rsb.info.nih.gov/nih-image/) was used for the densitometric analyses.
Antibodies
Anti-Anx2 (clone 5), -Anx6 (clone 67) and -Anx11 (clone 16) monoclonal antibodies were purchased from BD Biosciences (San Jose, CA, USA). Anti-phosphoserine (clone PSR-45) and anti-phosphotyrosine (clone PT-66) monoclonal antibodies were purchased from Sigma. Anti-actin monoclonal antibody (clone MAB1501) was purchased from Chemicon International Inc. (Temecula, CA, USA). Horseradish peroxidaseconjugated rabbit antibody against mouse IgG was purchased from Amersham Pharmacia Biotech, and biotin-labeled rabbit antibody against mouse IgG was purchased from Dako (Dako Japan Co. Ltd, Kyoto).
Immunoprecipitation and Western blot analysis
Tissue samples or pellets of cultured cells were homogenized in RIPA buffer (20 mM Tris, 0.1% SDS, 1% Triton X-100, 1% sodium deoxycholate, pH 7.4) with protease (complete mini, Roche) and phosphatase (1 mM Na 3 VO 4 ) inhibitors, and the supernatant collected after centrifugation at 15 000 g for 15 min was used. The protein concentration was determined with BCA protein reagents (Pierce, Rockford, IL, USA). Immunoprecipitation was performed as follows: 10 ml of Anx2 monoclonal antibody was added to 400 or 800 mg of lysate in a 100-ml volume, and incubated on ice for 3 h, followed by addition of protein A Sepharose CL-4B (Amersham Pharmacia Biotech) and incubation on ice for 1 h. After washing with 100 mM HEPES buffer (pH 8.0), the Sepharose beads were separated by centrifugation, and boiled with 100 ml of sample buffer containing 2-mercaptoethanol for 3 min. A measure of 20 ml of the supernatant was electrophoresed in each gel lane.
Western blotting was carried out using standard procedures after 10% SDS-PAGE under reducing conditions (4 mg of protein in each lane) and semidry blotting on polyvinylidene difluoride membranes (Immobilon, Millipore, Tokyo) as described (Toyokuni et al., 2003) .
Immunohistochemistry
The avidin-biotin complex method with alkaline phosphatase or peroxidase was used as described (Toyokuni et al., 1997b) . In some experiments, streptavidin-FITC (Vector) and propidium iodide for nuclear staining were used.
Transfection of Anx2
An expression vector containing the whole coding sequence of Anx2 was constructed as follows. At first, NM 019905 (GenBank; 43-1158) was amplified by PCR using rat kidney cDNA as template, using the primers rAnx2VF 5 0 -GGGGTACC(KpnI)CCACCATGTCTACTGTCCACGAA AT-3 0 and rAnx2VR 5 0 -GAGTTCAGGGGTCCATTA to include 'Kozak' consensus sequence. pcDEF3 vector under the control of the human polypeptide chain elongation factor 1a promoter (Goldman et al., 1996) was used. The PCR product and the vector were digested with KpnI and XbaI (Takara Bio), and ligated (pcDEF3-Anx2) with a DNA Ligation kit ver. 2 (Takara Bio). The sequence was confirmed with an ABI PRISM 377 sequencer.
Effectine (Qiagen, Tokyo) was used for transfection. The transfection efficiency and the expression of the transfected Anx2 were evaluated by in situ hybridization and Western blot analysis. For in situ hybridization, cells were cultured on fourchamber slides coated with collagen I (Iwaki, Tokyo) and fixed with 10% neutral formalin, and the Dako Genpoint system together with catalysed signal amplification (NEN Life Science Products, Inc., Boston, MA, USA) was used. The antisense oligo-DNA probe was biotin-5 0 -TACAGGGGCTTGTTCT GAATGCACTGAACCAGGTTC-3 0 , and the sense probe was 5 0 -biotin-GAACCTGGTTCAGTGCATTCAGAACAA GCCCCTGTG-3 0 .
Antisense treatment
The sense and antisense phosphorothioate oligonucleotides designed specifically for the rat Anx2 gene were obtained as a Biognostik custom design kit (Biognostik GmbH, Goettingen, Germany). The sense and antisense oligonucleotides were applied to each FRCC series cell line according to the manufacturer's protocol. Briefly, cells of each cell line were plated at a density of 10 4 -10 5 cells/well in 96-well microtiter plates (Corning, Tokyo), incubated for 24 h, washed twice with PBS(À) and placed in culture medium without FCS. Thereafter, sense or antisense oligonucleotides (final concentration 1 mM) and 5.2 ml TransIT-LT2 polyamine transfection reagent (PanVera Co., Madison, WI, USA) were added to the medium and cells were incubated in this mixture for the indicated duration (0, 1, 3, 6, 16, 24 and 36 h) . At 4 h after transfection, cells were washed twice with PBS(À) and returned to culture medium with FCS.
Cell proliferation assay
The cell proliferation assay was performed using an ELISA BrdU (colorimetric) kit (Boehringer Mannheim GmbH, Mannheim, Germany) following the manufacturer's protocol.
DNA fragmentation assay
The cellular DNA fragmentation assay was performed using a Cellular DNA Fragmentation ELISA kit (Boehringer Mannheim) according to the manufacturer's protocol.
TUNEL assay
For in situ examination of apoptosis, the TUNEL method was used. Cells were fixed with 4% paraformaldehyde in 10 mM PBS (pH 7.4) for 24 h at 41C, and an apoptosis in situ detection kit (Wako, Osaka, Japan) was used according to the manufacturer's instructions.
Statistical analysis
Statistical analyses were performed with an unpaired t-test, which was modified for unequal variances when necessary. Po0.05 was considered as statistically significant.
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